INTRAFOCAL INTERFERON THERAPY FOR RELAPSING WARTS

Abstract


Warts are benign formations of the skin, caused by human papillomaviruses. The efficiency of various treatments are discussed. Experience gained with intrafocal interferon therapy of relapsing warts is presented. This treatment is recommended as a method of choice for relapsing warts of the palms and soles, multiple vulgar warts, particularly located by the nails.

Full Text

Внутриочаговая интерферонотерапия рецидивирующих бородавок

References

  1. Bellew S.G., Quartarolo N., Janniger C.K. Childhood warts: an update. Cutis. 2004; 73(6): 379—84.
  2. Jablonska S., Majewski S., Obalek S., Orth G. Cutaneous warts. Clin. Dermatol. 1997; 15(3): 309—19.
  3. Plunkett A., Merlin K., Gill D., Zuo Y., Jolley D., Marks R. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int. J. Dermatol. 1999; 38(12): 901—8.
  4. Silverberg N.B. Human papillomavirus infections in children. Curr. Opin. Pediatr. 2004; 16(4): 402—9.
  5. Bouwes Bavinck J.N., Berkhout R.J. HPV infections and immunosuppression. Clin. Dermatol. 1997; 15(3):427—37.
  6. Delius H., Saegling B., Bergmann K., Shamanin V., de Villiers E.M. The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR. Virology. 1998; 240(2): 359—65.
  7. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324(1): 17—27.
  8. Holland T.T., Weber C.B., James W.D. Tender periungual nodules. Myrmecia (deep palmoplantar warts). Arch. Dermatol. 1992; 128(1): 105—8.
  9. Cohen P.R., Hebert A.A., Adler-Storthz K. Focal epithelial hyperplasia. Heck disease. Pediatr. Dermatol. 1993; 10(3): 245—51.
  10. Kwok C.S., Holland R., Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br. J. Dermatol. 2011; 165(2): 233—46. doi: 10.1111/j.1365-2133.2011.10218.x.
  11. Cockayne S., Hewitt C., Hicks K., Jayakody S., Kang'ombe A.R., Stamuli E., et al.; EVerT Team. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. Br Med. J. 2011; 342: d3271. doi: 10.1136/bmj.d3271.
  12. Gibbs S., Harvey I., Sterling J., Stark R. Local treatments for cutaneous warts: systematic review. Br. Med. J. 2002; 325(7362): 461.
  13. Gladsjo J.A., Alio Saenz A.B., Bergman J., Krikorian G., Cunningham B.B. 5% 5-fluorouracil cream for treatment of verruca vulgaris in children. Pediatr. Dermatol. 2009; 26(3): 279—85.
  14. Perrett C.M., Harwood C., Brown V. Topical 5% imiquimod treatment for refractory cutaneous warts. J. Am. Acad. Dermatol. 2004; 50(3): 41—5.
  15. Ewin D.M. Hypnotherapy for warts (verruca vulgaris). 41 consecutive cases with 33 cures. Am. J. Clin. Hypn. 1992; 35(1): 1—10.
  16. Bourke J.F., Berth-Jones J., Hutchinson P.E. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br. J. Dermatol. 1995; 132(2): 433—6.
  17. Gloster H.M.Jr., Roenigk R.K. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J. Am. Acad. Dermatol. 1995; 32(3): 436—41.
  18. Hughes P.S., Hughes A.P. Absence of human papillomavirus DNA in the plume of erbium: YAG laser-treated warts. J. Am. Acad. Dermatol. 1998; 38(3): 426—8.
  19. Sloan K., Haberman H., Lynde C.W. Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis. J. Cutan. Med. Surg. 1998; 2(3): 142—5.
  20. Horn T.D., Johnson S.M., Helm R.M., Roberson P.K. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch. Dermatol. 2005; 141(5): 589—94.
  21. Lewis T.G., Nydorf E.D. Intralesional bleomycin for warts: a review. J. Drugs Dermatol. 2006; 5(6): 499—504.
  22. Munn S.E., Higgins E., Marshall M., Clement M. A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br. J. Dermatol. 1996; 135(6): 969—71.
  23. Allam J.P., Hagemann T., Bieber T., Novak N. Successful treatment of therapy-resistant plantar verrucae vulgares with systemic interferon-beta. J. Dermatol. 2004; 31(7): 582—3.
  24. Aksakal A.B., Ozden M.G., Atahan C., Onder M. Successful treatment of verruca plantaris with a single sublesional injection of interferon-alpha2a. Clin. Exp. Dermatol. 2009; 34(1): 16—9.

Statistics

Views

Abstract - 27

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2013 Bagramova G.E., Sedova T.G., Khlebnikova A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies